IGC Pharma Inc
F:IGS1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IGC Pharma Inc
F:IGS1
|
US |
|
Kimball Electronics Inc
NASDAQ:KE
|
US |
|
Ultra Clean Holdings Inc
NASDAQ:UCTT
|
US |
|
Ionic Rare Earths Ltd
ASX:IXR
|
AU |
|
Minco Silver Corp
F:XYD
|
CA |
|
D
|
Diversified Healthcare Trust
F:SNF
|
US |
|
Kimball Electronics Inc
F:3C3
|
US |
|
U
|
Ucb SA
XMUN:UNC
|
BE |
|
K
|
Kainos Medicine Inc
KOSDAQ:284620
|
KR |
|
I
|
IntoCell Inc
KOSDAQ:287840
|
KR |
|
O
|
Orange Belgium NV
XMUN:MOS
|
BE |
|
Hellofresh SE
F:HFG0
|
DE |
|
Orange Belgium NV
F:MOS
|
BE |
|
H
|
Hellofresh SE
DUS:HFG
|
DE |
|
Konoike Transport Co Ltd
F:2KT
|
JP |
|
Odfjell SE
F:O7F1
|
NO |
|
Gale Pacific Ltd
ASX:GAP
|
AU |
Bankruptcy Probability
IGC Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IGC Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
IGC Pharma Inc
AMEX:IGC
|
28.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IGC Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IGC Pharma Inc has total debt of 149k USD. This includes both short-term (0 USD) and long-term (149k USD) debt.
You can find a full breakdown on its Balance Sheet.